Persistence of anti-human leukocyte antibodies in congenital heart disease late after surgery using allografts and whole blood

Journal of Heart and Lung Transplantation

Volumn 32, Issue 4, 2013, Pages 390-397

  O'Connor, Matthew J ^a   Lind, Curt ^b   Tang, Xinyu ^c   Gossett, Jeffrey ^c   Weber, Janice ^a   Monos, Dimitrios ^b   Shaddy, Robert E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

allografts; congenital heart disease; human leukocyte antibody; whole blood

Indexed keywords

HLA ANTIBODY;

ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; BLOOD TRANSFUSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; MALE; NORWOOD PROCEDURE; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ANTIBODIES; BLOOD VESSELS; CARDIAC SURGICAL PROCEDURES; CHILD; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; HEART DEFECTS, CONGENITAL; HLA ANTIGENS; HUMANS; INFANT; INFANT, NEWBORN; MALE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84875215969     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2012.12.009     Document Type: Article

References (24)

1. D.B. McElhinney, V.M. Reddy, and F.L. Hanley Homografts in congenital heart disease: current applications and future directions Isr J Med Sci 32 1996 880 885
2. Months Homann, J.C. Haehnel, N. Mendler, S.U. Paek, K. Holper, and H. Meisner Reconstruction of the RVOT with valved biological conduits: 25 years experience with allografts and xenografts Eur J Cardiothorac Surg 17 2000 624 630
3. J.S. Tweddell, A.N. Pelech, and P.C. Frommelt Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease Circulation 102 19 Suppl 3 2000 130 135
4. M.J.P. Welters, F.B.S. Oei, and M.D. Witvliet A broad and strong humoral immune response to donor HLA after implantation of cryopreserved human heart valve allografts Hum Immunol 63 2002 1019 1025
5. R.E. Shaddy, and J.A. Hawkins Immunology and failure of valved allografts in children Ann Thorac Surg 74 2002 1271 1275
6. V. Bautista-Hernandez, G.R. Marx, and K. Gauvreau Coarctectomy reduces neoaortic arch obstruction in hypoplastic left heart syndrome J Thorac Cardiovasc Surg 133 2007 1540 1546
7. D.K. Hooper, J.A. Hawkins, T.C. Fuller, T. Profaizer, and R.E. Shaddy Panel-reactive antibodies late after allograft implantation in children Ann Thorac Surg 79 2005 641 644
8. R.E. Shaddy, D.D. Hunter, and K.A. Osborn Prospective analysis of HLA immunogenicity of cryopreserved valved allografts used in pediatric heart surgery Circulation 94 1996 1063 1067
9. J.A. Hawkins, J.P. Breinholt, and L.M. Lambert Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients J Thorac Cardiovasc Surg 119 2000 324 330
10. S.R. Meyer, P.M. Campbell, and J.M. Rutledge Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation Eur J Cardiothorac Surg 27 2005 554 560
11. J.M. Cecka Calculated PRA (CPRA): the new measure of sensitization for transplant candidates Am J Transplant 10 2010 26 29
12. J.P. Breinholt, J.A. Hawkins, L.M. Lambert, T.C. Fuller, T. Profaizer, and R.E. Shaddy A prospective analysis of the immunogenicity of cryopreserved nonvalved allografts used in pediatric heart surgery Circulation 102 2000 179 182
13. R.E. Shaddy, D.D. Thompson, K.A. Osborne, J.A. Hawkins, and T.C. Fuller Persistence of human leukocyte antigen (HLA) antibodies after one year in children receiving cryopreserved valved allografts Am J Cardiol 80 1997 358 359
14. J.D. Smith, H. Ogino, D. Hunt, R.M. Laylor, M.L. Rose, and M.H. Yacoub Humoral immune response to human aortic valve homografts Ann Thorac Surg 60 1995 S127 S130
15. D.J. Goldberg, R.E. Shaddy, C. Ravishankar, and J. Rychik The failing Fontan: Etiology, diagnosis and management Expert Rev Cardiovasc Ther 9 2011 785 793
16. J. Stehlik, L.B. Edwards, and A.Y. Kucheryavaya The registry of the International Society for Heart and Lung Transplantation: twenty-eighth adult heart transplant Report-2011 J Heart Lung Transplant 30 2011 1078 1094
17. R.R. Davies, M.J. Russo, J. Yang, J.M. Quaegebeur, R.S. Mosca, and J.M. Chen Listing and transplanting adults with congenital heart disease Circulation 123 2011 759 767
18. W.T. Mahle, M.A. Tresler, and R.E. Edens Allosensitization and outcomes in pediatric heart transplantation J Heart Lung Transplant 30 2011 1221 1227
19. J.W. Rossano, D.L. Morales, and F. Zafar Impact of antibodies against human leukocyte antigens on long-term outcome in pediatric heart transplant patients: an analysis of the United Network for Organ Sharing database J Thorac Cardiovasc Surg 140 2010 694 699
20. C.E. Gruenwald, B.W. McCrindle, and L. Crawford-Lean Reconstituted fresh whole blood improves clinical outcomes compared with stored component blood therapy for neonates undergoing cardiopulmonary bypass for cardiac surgery: a randomized controlled trial J Thorac Cardiovasc Surg 136 2008 1442 1449
21. C. Manno, K. Hedberg, and H. Kim Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children Blood 77 1991 930 936
22. N. Moazami, S. Itescu, and M.R. Williams Argenziano months, Weinberg A, Oz MC. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support J Heart Lung Transplant 17 1998 876 880
23. J. Kobashigawa, Months Mehra, and L. West Report from a consensus conference on the sensitized patient awaiting heart transplantation J Heart Lung Transplant 28 2009 213 225
24. S.F. Shakar, and J. Lindenfeld Editorial commentary: all that glitters is not gold. J Heart Lung Transplant 31 2012 441 442